This company may still be operating, however this listing is no longer active. Find out why through their latest events.
La Jolla Pharmaceutical Future Growth
Future criteria checks 4/6
La Jolla Pharmaceutical is forecast to grow earnings and revenue by 59% and 19.8% per annum respectively while EPS is expected to grow by 55.8% per annum.
Key information
59.0%
Earnings growth rate
55.8%
EPS growth rate
Biotechs earnings growth
39.4%
Revenue growth rate
19.8%
Future return on equity
n/a
Analyst coverage
Low
Last updated
n/a
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:LJPP - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2024
77
16
N/A
N/A
1
12/31/2023
64
8
N/A
N/A
1
12/31/2022
47
1
N/A
N/A
1
6/30/2022
46
4
13
13
N/A
3/31/2022
52
5
14
14
N/A
12/31/2021
76
20
28
28
N/A
9/30/2021
74
12
18
18
N/A
6/30/2021
70
3
7
7
N/A
3/31/2021
60
-16
-8
-8
N/A
12/31/2020
33
-39
-38
-38
N/A
9/30/2020
30
-61
-48
-47
N/A
6/30/2020
26
-79
-57
-56
N/A
3/31/2020
26
-93
-65
-65
N/A
12/31/2019
23
-117
-86
-85
N/A
9/30/2019
20
-137
-101
-100
N/A
6/30/2019
18
-158
-119
-118
N/A
3/31/2019
14
-181
-141
-139
N/A
12/31/2018
10
-199
-155
-152
N/A
9/30/2018
6
-193
-153
-146
N/A
6/30/2018
2
-168
-136
-127
N/A
3/31/2018
1
-142
-118
-109
N/A
12/31/2017
N/A
-115
-94
-85
N/A
9/30/2017
0
-101
-83
-78
N/A
6/30/2017
0
-96
-78
-75
N/A
3/31/2017
0
-85
-70
-68
N/A
12/31/2016
1
-78
-61
-59
N/A
9/30/2016
1
-65
-50
-49
N/A
6/30/2016
2
-54
-40
-39
N/A
3/31/2016
1
-49
N/A
-33
N/A
12/31/2015
1
-42
N/A
-25
N/A
9/30/2015
1
-37
N/A
-22
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LJPP's forecast earnings growth (59% per year) is above the savings rate (-0.01%).
Earnings vs Market: LJPP's earnings (59% per year) are forecast to grow faster than the German market (14.7% per year).
High Growth Earnings: LJPP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LJPP's revenue (19.8% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: LJPP's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LJPP's Return on Equity is forecast to be high in 3 years time